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ABSTRACT 
Pasteurella multocida serotype B:2 causes hemorrhagic septicemia in cattle and buffalo. The 
invasion mechanism of the bacterium when invading the bloodstream is unclear. This study 
aimed to characterize the effects of immunomodulatory molecules, namely dexamethasone 
and lipopolysaccharide, on the invasion efficiency of P. multocida serotype B:2 toward 
bovine aortic endothelial cells (BAECs) and the involvement of actin microfilaments in the 
invasion mechanism. The results imply that treatment of BAECs with lipopolysaccharide at 
100 ng/mL for 24 h significantly increases the intracellular bacteria number per cell (p < 
0.01) compared with those in untreated and dexamethasone-treated cells. The 
lipopolysaccharide-treated cells showed a significant decrease in F-actin expression and an 
increase in G-actin expression (p < 0.001), indicating actin depolymerization of BAECs. 
However, no significant differences were detected in the invasion efficiency and actin 
filament reorganization between the dexamethasone-treated and untreated cells. Transmission 
electron microscopy showed that P. multocida B:2 resided in a vacuolar compartment of 
dexamethasone-treated and untreated cells, whereas the bacteria resided in cellular membrane 
of lipopolysaccharide-treated cells. The results suggest that lipopolysaccharide destabilizes 
the actin filaments of BAECs, which could facilitate the invasion of P. multocida B:2 into 
BAECs. 
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